Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading ->
In just one year, COVID-19 has undone more than a decade’s progress in the fight against tuberculosis (TB), health experts said on Thursday. While COVID-19 fatality numbers are decreasing worldwide, TB-related deaths remain steady at 4000 cases a day – an occurrence experts partly attribute to limited access to TB treatment services during COVID lockdown […] Continue reading ->
COVID-19 has presented new risks to the African continent, with already limited financial resources needed to respond to climate hazards and natural disasters now being diverted to fight the pandemic. The pandemic has made it all the more challenging to ensure there is adequate disaster financing on the continent, and this now needs urgent attention, […] Continue reading ->
The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer.  The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading ->
South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks.  However, overall supplies remain far short of the needs – even for the health sector.  The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading ->
Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine.     AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading ->
Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally.  The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading ->